Daftary, AMitchell, E.M.HReid, M.J.AFekadu, EGoosby, E2024-10-022024-10-022018-11Daftary A, Mitchell EMH, Reid MJA, Fekadu E, Goosby E. To End TB, First-Ever High-Level Meeting on Tuberculosis Must Address Stigma. Am J Trop Med Hyg. 2018 Nov;99(5):1114-1116. doi: 10.4269/ajtmh.18-0591.10.4269/ajtmh.18-0591https://pubmed.ncbi.nlm.nih.gov/30226149/https://hdl.handle.net/11288/597683World leaders gather to consolidate their commitment to ending tuberculosis (TB). Vital to the success of renewed efforts is an overdue recognition of the pervasive and pernicious influence of TB stigma. TB stigma is sustained in structures, policies, traditions, and norms. Innovative modifications to infection control, drug dispensing, and surveillance practices are required to increase demand for TB screening and effective therapeutic alliances among those diagnosed. The authors argue that reducing TB stigma requires a scientific and inclusive process, with prominent roles for TB survivors and a willingness to integrate and learn from other stigmatized conditions.enArticle